ArticleBMC cancer2024

Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis.

Teppei Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.